BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 21636786)

  • 1. Increased Wingless (Wnt) signaling in pituitary progenitor/stem cells gives rise to pituitary tumors in mice and humans.
    Gaston-Massuet C; Andoniadou CL; Signore M; Jayakody SA; Charolidi N; Kyeyune R; Vernay B; Jacques TS; Taketo MM; Le Tissier P; Dattani MT; Martinez-Barbera JP
    Proc Natl Acad Sci U S A; 2011 Jul; 108(28):11482-7. PubMed ID: 21636786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-catenin stimulates pituitary stem cells to form aggressive tumors.
    Camper SA
    Proc Natl Acad Sci U S A; 2011 Jul; 108(28):11303-4. PubMed ID: 21719710
    [No Abstract]   [Full Text] [Related]  

  • 3. Regulation of Pituitary Progenitor Differentiation by β-Catenin.
    Youngblood JL; Coleman TF; Davis SW
    Endocrinology; 2018 Sep; 159(9):3287-3305. PubMed ID: 30085028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 60 YEARS OF NEUROENDOCRINOLOGY: Biology of human craniopharyngioma: lessons from mouse models.
    Martinez-Barbera JP
    J Endocrinol; 2015 Aug; 226(2):T161-72. PubMed ID: 25926515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MAPK pathway control of stem cell proliferation and differentiation in the embryonic pituitary provides insights into the pathogenesis of papillary craniopharyngioma.
    Haston S; Pozzi S; Carreno G; Manshaei S; Panousopoulos L; Gonzalez-Meljem JM; Apps JR; Virasami A; Thavaraj S; Gutteridge A; Forshew T; Marais R; Brandner S; Jacques TS; Andoniadou CL; Martinez-Barbera JP
    Development; 2017 Jun; 144(12):2141-2152. PubMed ID: 28506993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concise Review: Paracrine Role of Stem Cells in Pituitary Tumors: A Focus on Adamantinomatous Craniopharyngioma.
    Martinez-Barbera JP; Andoniadou CL
    Stem Cells; 2016 Feb; 34(2):268-76. PubMed ID: 26763580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and cellular pathogenesis of adamantinomatous craniopharyngioma.
    Martinez-Barbera JP
    Neuropathol Appl Neurobiol; 2015 Oct; 41(6):721-32. PubMed ID: 25611703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of novel pathways involved in the pathogenesis of human adamantinomatous craniopharyngioma.
    Andoniadou CL; Gaston-Massuet C; Reddy R; Schneider RP; Blasco MA; Le Tissier P; Jacques TS; Pevny LH; Dattani MT; Martinez-Barbera JP
    Acta Neuropathol; 2012 Aug; 124(2):259-71. PubMed ID: 22349813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Craniopharyngiomas express embryonic stem cell markers (SOX2, OCT4, KLF4, and SOX9) as pituitary stem cells but do not coexpress RET/GFRA3 receptors.
    Garcia-Lavandeira M; Saez C; Diaz-Rodriguez E; Perez-Romero S; Senra A; Dieguez C; Japon MA; Alvarez CV
    J Clin Endocrinol Metab; 2012 Jan; 97(1):E80-7. PubMed ID: 22031517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathology and pathogenesis of craniopharyngiomas.
    Larkin SJ; Ansorge O
    Pituitary; 2013 Mar; 16(1):9-17. PubMed ID: 22886701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PROP1 and CTNNB1 expression in adamantinomatous craniopharyngiomas with or without β-catenin mutations.
    Cani CM; Matushita H; Carvalho LR; Soares IC; Brito LP; Almeida MQ; Mendonça BB
    Clinics (Sao Paulo); 2011; 66(11):1849-54. PubMed ID: 22086512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Target gene activation of the Wnt signaling pathway in nuclear beta-catenin accumulating cells of adamantinomatous craniopharyngiomas.
    Hölsken A; Kreutzer J; Hofmann BM; Hans V; Oppel F; Buchfelder M; Fahlbusch R; Blümcke I; Buslei R
    Brain Pathol; 2009 Jul; 19(3):357-64. PubMed ID: 18540944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour cell migration in adamantinomatous craniopharyngiomas is promoted by activated Wnt-signalling.
    Hölsken A; Buchfelder M; Fahlbusch R; Blümcke I; Buslei R
    Acta Neuropathol; 2010 May; 119(5):631-9. PubMed ID: 20131060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stem cell senescence drives age-attenuated induction of pituitary tumours in mouse models of paediatric craniopharyngioma.
    Gonzalez-Meljem JM; Haston S; Carreno G; Apps JR; Pozzi S; Stache C; Kaushal G; Virasami A; Panousopoulos L; Mousavy-Gharavy SN; Guerrero A; Rashid M; Jani N; Goding CR; Jacques TS; Adams DJ; Gil J; Andoniadou CL; Martinez-Barbera JP
    Nat Commun; 2017 Nov; 8(1):1819. PubMed ID: 29180744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Wnt4 in human pituitary adenomas regulates activation of the beta-catenin-independent pathway.
    Miyakoshi T; Takei M; Kajiya H; Egashira N; Takekoshi S; Teramoto A; Osamura RY
    Endocr Pathol; 2008; 19(4):261-73. PubMed ID: 19034702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CTNNB1 gene mutations, pituitary transcription factors, and MicroRNA expression involvement in the pathogenesis of adamantinomatous craniopharyngiomas.
    Campanini ML; Colli LM; Paixao BM; Cabral TP; Amaral FC; Machado HR; Neder LS; Saggioro F; Moreira AC; Antonini SR; de Castro M
    Horm Cancer; 2010 Aug; 1(4):187-96. PubMed ID: 21761366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible linkage between specific histological structures and aberrant reactivation of the Wnt pathway in adamantinomatous craniopharyngioma.
    Kato K; Nakatani Y; Kanno H; Inayama Y; Ijiri R; Nagahara N; Miyake T; Tanaka M; Ito Y; Aida N; Tachibana K; Sekido K; Tanaka Y
    J Pathol; 2004 Jul; 203(3):814-21. PubMed ID: 15221941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRAF V600E mutations are characteristic for papillary craniopharyngioma and may coexist with CTNNB1-mutated adamantinomatous craniopharyngioma.
    Larkin SJ; Preda V; Karavitaki N; Grossman A; Ansorge O
    Acta Neuropathol; 2014; 127(6):927-9. PubMed ID: 24715106
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of the Canonical Wnt Pathway Activation on the Pathogenesis and Prognosis of Adamantinomatous Craniopharyngiomas.
    Jucá CEB; Colli LM; Martins CS; Campanini ML; Paixão B; Jucá RV; Saggioro FP; de Oliveira RS; Moreira AC; Machado HR; Neder L; Antonini SR; de Castro M
    Horm Metab Res; 2018 Jul; 50(7):575-581. PubMed ID: 29625497
    [No Abstract]   [Full Text] [Related]  

  • 20. Canonical WNT Signaling Regulates the Pituitary Organizer and Pituitary Gland Formation.
    Osmundsen AM; Keisler JL; Taketo MM; Davis SW
    Endocrinology; 2017 Oct; 158(10):3339-3353. PubMed ID: 28938441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.